Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Net Income (2016 - 2025)

Macrogenics (MGNX) has disclosed Net Income for 14 consecutive years, with -$14.2 million as the latest value for Q4 2025.

  • Quarterly Net Income rose 8.21% to -$14.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$76.3 million through Dec 2025, down 9.53% year-over-year, with the annual reading at -$74.6 million for FY2025, 11.43% down from the prior year.
  • Net Income for Q4 2025 was -$14.2 million at Macrogenics, down from $16.8 million in the prior quarter.
  • The five-year high for Net Income was $56.3 million in Q3 2024, with the low at -$66.6 million in Q1 2022.
  • Average Net Income over 5 years is -$32.0 million, with a median of -$41.0 million recorded in 2021.
  • The sharpest move saw Net Income plummeted 2583.69% in 2021, then soared 258.61% in 2024.
  • Over 5 years, Net Income stood at -$58.2 million in 2021, then surged by 120.58% to $12.0 million in 2022, then crashed by 511.87% to -$49.4 million in 2023, then skyrocketed by 68.75% to -$15.4 million in 2024, then grew by 8.21% to -$14.2 million in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at -$14.2 million, $16.8 million, and -$36.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.